Comprehensive Multispectroscopic and Molecular Docking Investigation of the Anticancer Drug Idarubicin–Bovine Serum Albumin Interaction
Luminescence · 2026-05 · 41 (5)
DOI: 10.1002/bio.70513 ↗Kurz gefasst
Fachartikel in der Zeitschrift Luminescence, online erschienen am 21.05.2026. Verfasst von Mehmetcan Bilkay und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Analytical Chemistry, Faculty of Pharmacy, Gazi University, Ankara, Türkiye. Hauptthemen laut MEDLINE: Idarubicin, Serum Albumin, Bovine, Molecular Docking Simulation, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Türkiye Bilimsel ve Teknolojik Araştirma Kurumu.
Abstract (Originalsprache)
Understanding the binding mechanism of idarubicin (IDA), a chemotherapeutic agent used in the treatment of acute myeloid leukemia (AML), with bovine serum albumin (BSA) is essential for elucidating its toxicity and pharmacodynamic and pharmacokinetic behavior and for supporting the development of novel drugs. In this study, the interaction between IDA and BSA was comprehensively investigated using spectroscopic techniques, including steady‐state fluorescence, 3D fluorescence, synchronous fluorescence, competitive displacement assays, UV–Vis absorption spectroscopy, and Fourier transform infrared (FT‐IR) spectroscopy, along with dynamic light scattering (DLS) and molecular docking analysis. The interaction was confirmed by fluorescence and UV–Vis spectra, and the binding constant was determined as K a = 1.74 × 10 4 M −1 . Fluorescence quenching analysis indicated a predominantly static quenching mechanism, suggesting the formation of a ground‐state complex. Thermodynamic results revealed that hydrogen bonding, hydrophobic interactions, and van der Waals forces play dominant roles in the binding process. Furthermore, 3D and synchronous fluorescence studies demonstrated that IDA alters the polarity of the BSA microenvironment. Molecular docking and displacement studies showed that IDA binds to all three BSA sites, with a significantly higher affinity for Site III compared to Site I and Site II. These findings provide valuable insight into the IDA–BSA interaction mechanism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Analytical Chemistry, Faculty of Pharmacy, Gazi University, Ankara, Türkiye.
- Bioinformatics Programme, Institute of Biological Sciences, Faculty of Science, University of Malaya, Kuala Lumpur, Malaysia.
- Centre of Research for Computational Sciences and Informatics for Biology, Bioindustry, Environment, Agriculture and Healthcare, University of Malaya, Kuala Lumpur, Malaysia.
ORCID-Profile: Mehmetcan Bilkay
Förderung
- Türkiye Bilimsel ve Teknolojik Araştirma Kurumu
Zitieren
APA
Bilkay, M., Gharanjik, A., Hidayat, A. F. A., Mohamad, S. B., & Kara, H. E. S. (2026). Comprehensive Multispectroscopic and Molecular Docking Investigation of the Anticancer Drug Idarubicin–Bovine Serum Albumin Interaction. Luminescence, 41(5). https://doi.org/10.1002/bio.70513
Vancouver
Bilkay M, Gharanjik A, Hidayat AFA, Mohamad SB, Kara HES. Comprehensive Multispectroscopic and Molecular Docking Investigation of the Anticancer Drug Idarubicin–Bovine Serum Albumin Interaction. Luminescence. 2026;41(5). doi:10.1002/bio.70513
BibTeX
@article{Bilkay2026,
author = {Bilkay, Mehmetcan and Gharanjik, Aytekin and Hidayat, Ahmad Fadhlurrahman Ahmad and Mohamad, Saharuddin B and Kara, Hayriye Eda Satana},
title = {Comprehensive Multispectroscopic and Molecular Docking Investigation of the Anticancer Drug Idarubicin–Bovine Serum Albumin Interaction},
journal = {Luminescence},
year = {2026},
volume = {41},
number = {5},
doi = {10.1002/bio.70513}
}
EUVIMED